Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Long-Term Debt Repayments (2018)

TransMedics has reported Long-Term Debt Repayments over the past 1 years, most recently at $6.7 million for Q2 2018.

  • Quarterly results put Long-Term Debt Repayments at $6.7 million for Q2 2018, changed N/A from a year ago — trailing twelve months through Dec 2022 was $6.7 million (changed N/A YoY), and the annual figure for FY2022 was $36.0 million, changed.
  • Long-Term Debt Repayments for Q2 2018 was $6.7 million at TransMedics, up from $892000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for TMDX hit a ceiling of $6.7 million in Q2 2018 and a floor of $892000.0 in Q1 2018.